Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.34 |
| ▸ | CA2 known ✓ | P00918 | 3/20 | 0.33 |
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.33 |
| ▸ | CA4 known ✓ | P22748 | 2/20 | 0.33 |
| ▸ | CA12 known ✓ | O43570 | 2/20 | 0.33 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.33 |
| ▸ | PKLR | P30613 | 3/20 | 0.40 |
| ▸ | RAD51 | Q06609 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.37 |
| ▸ | PGAM1 | P18669 | 2/20 | 0.37 |
| ▸ | DUSP5 | Q16690 | 1/20 | 0.37 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.36 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29566258 | 1.00 | PKLR (0.40) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| SCHEMBL6915130 | 0.95 | RAD51 (0.38) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| SCHEMBL6916722 | 0.95 | RAD51 (0.38) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| Potassium Ion SCHEMBL15525174 | 0.95 | RAD51 (0.42) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| SCHEMBL6917448 | 0.95 | RAD51 (0.38) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| SCHEMBL6913789 | 0.95 | RAD51 (0.38) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| SCHEMBL6914923 | 0.95 | KMT2A (0.39) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| Zinc Ion SCHEMBL6915012 | 0.95 | RAD51 (0.38) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| SCHEMBL6915146 | 0.95 | RAD51 (0.38) | PKLRRAD51PTPN1PGAM1DUSP5 | |
| SCHEMBL6913536 | 0.95 | RAD51 (0.38) | PKLRRAD51PTPN1PGAM1DUSP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4611104-A1 | NON-AQUEOUS ELECTROLYTE, SODIUM-ION BATTERY CONTAINING SAME, AND ELECTRICAL APPARATUS | Contemporary Amperex Technology (Hong Kong) Limited (HK) | 2025-09-03 | — | — | EP | claimed |
| US-20250219149-A1 | NON-AQUEOUS ELECTROLYTE AND SODIUM-ION BATTERY AND ELECTRIC APPARATUS INCLUDING SUCH ELECTROLYTE | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-07-03 | — | — | US | claimed |
| CN-119895619-A | Nonaqueous electrolyte, sodium ion battery including the same, and electric device | 宁德时代新能源科技股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-118326465-B | Nickel-palladium-gold electroplating surface treatment liquid suitable for packaging substrate | 深圳创智芯联科技股份有限公司 | 2024-08-06 | — | — | CN | claimed |
| WO-2024152146-A1 | NON-AQUEOUS ELECTROLYTE, SODIUM-ION BATTERY CONTAINING SAME, AND ELECTRICAL APPARATUS | 宁德时代新能源科技股份有限公司 | 2024-07-25 | — | — | WO | claimed |
| CN-118326465-A | Nickel-palladium-gold electroplating surface treatment process formula suitable for packaging substrate | 深圳创智芯联科技股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-117758244-A | Chemical nickel-plating palladium-gold solution process formula for aluminum substrate of power chip | 深圳创智芯联科技股份有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117488290-A | Chemical palladium plating solution process formula for aluminum substrate of chip | 深圳市溢诚电子科技有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-116590001-A | Ligand-passivated red light perovskite quantum dot with stable luminescence performance, and preparation method and application thereof | 上海大学 | 2023-08-15 | — | — | CN | claimed |
| EP-4611104-A1 | NON-AQUEOUS ELECTROLYTE, SODIUM-ION BATTERY CONTAINING SAME, AND ELECTRICAL APPARATUS | Contemporary Amperex Technology (Hong Kong) Limited (HK) | 2025-09-03 | — | — | EP | disclosed |
| US-12384785-B2 | Procedure for the formation of 2H-benzotriazole bodies and congeners | BASF SE (DE) | 2025-08-12 | — | — | US | disclosed |
| US-20250219149-A1 | NON-AQUEOUS ELECTROLYTE AND SODIUM-ION BATTERY AND ELECTRIC APPARATUS INCLUDING SUCH ELECTROLYTE | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2025-07-03 | — | — | US | disclosed |
| CN-117758244-B | Chemical nickel-plating palladium-gold solution process formula for aluminum substrate of power chip | 深圳创智芯联科技股份有限公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118326465-B | Nickel-palladium-gold electroplating surface treatment liquid suitable for packaging substrate | 深圳创智芯联科技股份有限公司 | 2024-08-06 | — | — | CN | disclosed |
| EP-2085373-B1 | METHOD FOR PRODUCING CARBONYL COMPOUND AN PRO-OXIDANT USED FOR PRODUCTION OF CARBONYL COMPOUND | UNIV NAGOYA NAT UNIV CORP (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-20100041917-A1 | PROCESS FOR PREPARATION OF CARBONYL COMPOUND AND PRO-OXIDANT FOR PREPARATION OF CARBONYL COMPOUND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2010-02-18 | — | — | US | disclosed |
| US-20090286176-A1 | ELECTROPHOTOGRAPHIC COLOR TONER | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-11-19 | — | — | US | disclosed |
| CN-101541725-A | Method for producing carbonyl compound an pro-oxidant used for production of carbonyl compound | UNIV NAGOYA NAT UNIV CORP (JP) | 2009-09-23 | — | — | CN | disclosed |
| EP-2085373-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND AN PRO-OXIDANT USED FOR PRODUCTION OF CARBONYL COMPOUND | National University Corporation Nagoya University (JP) | 2009-08-05 | — | — | EP | disclosed |
| EP-1201238-A1 | SULFONAMIDE DERIVATIVES AND REMEDIES FOR ALLODYNIA | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041917-A1 | PROCESS FOR PREPARATION OF CARBONYL COMPOUND AND PRO-OXIDANT FOR PREPARATION OF CARBONYL COMPOUND | CBR1, CBR3, NOX4 | THRB 3019/4885CA2 757/4885CA1 598/4885 |
| US-12384785-B2 | Procedure for the formation of 2H-benzotriazole bodies and congeners | GABBR1, SULT2A1, UGT2B7 | THRB 336/4885CA2 4480/4885CA1 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.